Time Well Spent: Lung Cancer Trials Offer Improved Survival Without Added Burden
Concerns about the time demands of clinical trials often deter cancer patients from enrolling. But a new study, published last month in JAMA Network Open, offers a reassuring counterpoint: For people with advanced non-small cell lung cancer (NSCLC), trial participation may not increase the time spent receiving care. It may even reduce hospitalizations.A group of researchers, led by Timothy P. Hanna, M.D., Ph.D., at Queen’s University in Ontario, analyzed data from 250 patients who died between 2...